文献速递肝病消化道肿瘤与早癌

GATAD1通过基因扩增表达上调直接诱导PRL3促进肝癌

Increased expression of GATA zinc finger domain containing 1 through gene amplification promotes liver cancer by directly inducing phosphatase of regenerating liver 3.
PubMed 文献 · Hepatology · 2018-03-23

研究发现转录因子GATAD1在肝细胞癌中因基因扩增而显著上调,76.6%(85/111)的原发肝癌表达GATAD1蛋白而正常肝组织沉默。GATAD1通过结合PRL3启动子直接诱导其转录,激活Akt信号通路,促进肝癌细胞增殖、迁移和侵袭并抑制凋亡。GATAD1高核表达是肝癌患者不良生存的独立预后因素。

要点

  • GATAD1在76.6%(85/111)原发肝癌中表达,正常肝组织沉默,基因扩增与过表达正相关(R=0.629,P<0.0001)。
  • GATAD1直接结合PRL3启动子诱导其转录,激活Akt信号通路,敲低PRL3可削弱GATAD1的致瘤效应。
  • GATAD1高核蛋白表达是肝癌患者不良生存的独立预后因素。

核心结论

  • GATAD1通过直接诱导PRL3转录激活Akt信号通路,在肝细胞癌中发挥关键致癌作用。
  • GATAD1可能作为肝癌患者独立的预后不良因素。

研究设计与样本

  • 研究检测了111例原发肝细胞癌中GATAD1蛋白表达(76.6%,85/111),并分析基因扩增与过表达的相关性(R=0.629,P<0.0001)。
  • 在肝癌细胞系和异种移植及原位小鼠模型中研究GATAD1的生物学功能,通过RNA测序和染色质免疫沉淀-PCR鉴定PRL3为直接靶点。

主要发现

  • GATAD1蛋白在76.6%的原发肝癌中表达(85/111),正常肝组织沉默,基因扩增与过表达正相关(R=0.629,P<0.0001)。
  • GATAD1促进肝癌细胞增殖、G1-S期细胞周期转换和迁移/侵袭,抑制凋亡,并在小鼠模型中促进肿瘤生长和肺转移。
  • GATAD1通过结合PRL3启动子诱导其转录;敲低PRL3可减弱GATAD1的致瘤效应,并消除GATAD1对Akt信号通路的激活。
  • PRL3通过使PTEN酪氨酸残基去磷酸化而降低PTEN蛋白,从而激活Akt信号。
  • PRL3抑制剂5-[[5-溴-2-[(2-溴苯基)甲氧基]苯基]亚甲基]-2-硫代-4-噻唑烷二酮通过抑制Akt激活显著抑制肝癌生长。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: We identified that GATA zinc finger domain containing 1 (GATAD1), a transcriptional factor, was significantly up-regulated in hepatocellular carcinoma (HCC) through gene amplification. We demonstrated the critical role, molecular mechanisms, and clinical implications of GATAD1 as a novel oncogenic factor in HCC. We found that GATAD1 protein was expressed in 76.6% of primary HCCs (85/111) but silenced in normal liver tissues. Gene amplification of GATAD1 was positively correlated with its overexpression in primary HCCs (R = 0.629, P < 0.0001). GATAD1 significantly increased cell proliferation, G1 -S cell cycle transition, and migration/invasion but suppressed apoptosis in liver cell lines and promoted tumor growth and lung metastasis in both xenograft and orthotopic mouse models. Mechanistically, GATAD1 induced the transcriptional expression of phosphatase of regenerating liver 3 (PRL3) by binding to its promoter identified by RNA sequencing and chromatin immunoprecipitation-PCR analyses. PRL3 played an oncogenic role in HCC. Knockdown of PRL3 blunted the tumorigenic effect of GATAD1. In addition, GATAD1 activated Akt signaling, evidenced by increased phosphorylation levels of total Akt, Akt1, Akt2, and Akt target glycogen synthase kinase 3β, while knockdown of PRL3 abolished this effect of GATAD1. We further unveiled that PRL3 activated Akt signaling by dephosphorylating phosphatase and tensin homolog at tyrosine residue, thus reducing phosphatase and tensin homolog protein. The PRL3 inhibitor 5-[[5-bromo-2-[(2-bromophenyl)methoxy]phenyl]methylene]-2-thioxo-4-thiazolidinone significantly suppressed HCC growth by inhibiting Akt activation. Moreover, high GATAD1 nuclear protein expression was associated with poor survival of HCC patients as an independent prognostic factor. CONCLUSION: GATAD1 plays a pivotal oncogenic role in HCC by directly inducing PRL3 transcription to activate the Akt signaling pathway. GATAD1 may serve as an independent poor prognostic factor for HCC patients. (Hepatology 2018;67:2302-2319).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Sun W, Zhang Y, Wong KC, et al. Increased expression of GATA zinc finger domain containing 1 through gene amplification promotes liver cancer by directly inducing phosphatase of regenerating liver 3. Hepatology. 2018. PMID: 29266303. doi:10.1002/hep.29750

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。